Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ESMC NASDAQ:HSCS NASDAQ:LFWD OTCMKTS:SIGY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESMCEscalon Medical$0.35+12.9%$0.32$0.11▼$0.46$2.60M0.3518,066 shs2,923 shsHSCSHeartSciences$3.01-9.9%$3.66$2.52▼$6.47$6.86M2.5758,486 shs100,212 shsLFWDLifeward$0.59+0.1%$0.68$0.50▼$4.00$9.19M0.161.23 million shs295,494 shsSIGYSigyn Therapeutics$4.00+8.7%$3.15$2.49▼$5.70$6.44M-1.17922 shs2,000 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESMCEscalon Medical+12.90%+12.00%-10.26%+19.78%+207.02%HSCSHeartSciences+0.91%+0.30%-1.47%-6.44%+18.44%LFWDLifeward+4.38%+5.01%-17.21%-46.87%-81.68%SIGYSigyn Therapeutics0.00%-13.04%+42.86%+45.45%-30.43%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESMCEscalon Medical$0.35+12.9%$0.32$0.11▼$0.46$2.60M0.3518,066 shs2,923 shsHSCSHeartSciences$3.01-9.9%$3.66$2.52▼$6.47$6.86M2.5758,486 shs100,212 shsLFWDLifeward$0.59+0.1%$0.68$0.50▼$4.00$9.19M0.161.23 million shs295,494 shsSIGYSigyn Therapeutics$4.00+8.7%$3.15$2.49▼$5.70$6.44M-1.17922 shs2,000 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESMCEscalon Medical+12.90%+12.00%-10.26%+19.78%+207.02%HSCSHeartSciences+0.91%+0.30%-1.47%-6.44%+18.44%LFWDLifeward+4.38%+5.01%-17.21%-46.87%-81.68%SIGYSigyn Therapeutics0.00%-13.04%+42.86%+45.45%-30.43%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESMCEscalon Medical 0.00N/AN/AN/AHSCSHeartSciences 3.00Buy$13.00331.89% UpsideLFWDLifeward 3.00Buy$9.001,438.46% UpsideSIGYSigyn Therapeutics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESMCEscalon Medical$11.98M0.22$0.04 per share8.60N/A∞HSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/ALFWDLifeward$24.43M0.38N/AN/A$2.14 per share0.27SIGYSigyn TherapeuticsN/AN/AN/AN/A($2.78) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESMCEscalon Medical-$130K$0.057.00∞N/A4.70%45.60%12.66%N/AHSCSHeartSciences-$8.77M-$9.36N/AN/AN/AN/A-293.60%-135.39%N/ALFWDLifeward-$28.94M-$3.12N/AN/AN/A-121.80%-137.91%-90.28%11/11/2025 (Estimated)SIGYSigyn Therapeutics-$3.34M-$4.77N/A∞N/AN/AN/A-2,842.57%N/ALatest ESMC, LFWD, HSCS, and SIGY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/11/2025Q1 2026HSCSHeartSciences-$2.41-$1.58+$0.83-$1.58N/AN/A8/14/2025Q2 2025LFWDLifeward-$0.25-$0.58-$0.33-$0.58$6.62 million$5.72 million7/24/2025Q4 2025HSCSHeartSciences-$2.51-$1.88+$0.63-$1.88N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthESMCEscalon MedicalN/AN/AN/AN/AN/AHSCSHeartSciencesN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/ALatest ESMC, LFWD, HSCS, and SIGY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/2/2025SIGYSigyn Therapeuticsquarterly$0.3227.94%10/24/202510/24/202511/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESMCEscalon Medical0.141.921.23HSCSHeartSciencesN/A0.590.41LFWDLifewardN/A2.001.26SIGYSigyn TherapeuticsN/AN/A0.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESMCEscalon MedicalN/AHSCSHeartSciences17.24%LFWDLifeward26.76%SIGYSigyn Therapeutics10.01%Insider OwnershipCompanyInsider OwnershipESMCEscalon Medical1.90%HSCSHeartSciences1.80%LFWDLifeward2.70%SIGYSigyn Therapeutics78.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESMCEscalon Medical407.42 million7.27 millionNot OptionableHSCSHeartSciences102.28 million2.24 millionNot OptionableLFWDLifeward6015.71 million15.28 millionOptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableESMC, LFWD, HSCS, and SIGY HeadlinesRecent News About These CompaniesSigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory BoardSeptember 11 at 10:34 AM | finance.yahoo.comSigyn Therapeutics Announces Cardiovascular Disease StudySeptember 3, 2025 | finance.yahoo.comSigyn Therapeutics Secures Convertible Note AgreementAugust 15, 2025 | msn.comSigyn Therapeutics Delays 10-Q FilingAugust 15, 2025 | tipranks.comRETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.July 1, 2025 | accessnewswire.comAGoldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.July 1, 2025 | accessnewswire.comASigyn Therapeutics Delays Q1 2025 10-Q FilingMay 15, 2025 | tipranks.comSigyn Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comSigyn CEO Note: An Emerging New Industry, 15 Years in the MakingMarch 12, 2025 | finance.yahoo.comSigyn CEO Note: Combating the Rising Threat of New Pandemic VirusesMarch 5, 2025 | finance.yahoo.comSigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare AnalystFebruary 25, 2025 | finance.yahoo.comSigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | financialpost.comFSigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor ConferenceFebruary 5, 2025 | globenewswire.comSigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of DirectorsJanuary 29, 2025 | finance.yahoo.comSigyn Therapeutics, Inc. (SIGY)December 21, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 76 Day 2 on October 31 Register NowOctober 30, 2024 | markets.businessinsider.comPresenting on the Emerging Growth Conference 74 Day 2 on August 22 Register NowAugust 21, 2024 | finance.yahoo.comOTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand ViewingAugust 2, 2024 | finance.yahoo.comSigyn Therapeutics Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finance.yahoo.comSigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"May 7, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeESMC, LFWD, HSCS, and SIGY Company DescriptionsEscalon Medical OTCMKTS:ESMC$0.35 +0.04 (+12.90%) As of 09:48 AM EasternEscalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.HeartSciences NASDAQ:HSCS$3.01 -0.33 (-9.88%) Closing price 04:00 PM EasternExtended Trading$3.07 +0.06 (+1.99%) As of 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Lifeward NASDAQ:LFWD$0.58 +0.00 (+0.10%) Closing price 04:00 PM EasternExtended Trading$0.59 +0.01 (+0.85%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.Sigyn Therapeutics OTCMKTS:SIGY$4.00 +0.32 (+8.70%) As of 09/11/2025 01:10 PM EasternSigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Why Micron Stock Could Outperform NVIDIA in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
